Back
Y-mAbs Therapeutics Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
29
YMAB
Y-mAbs Therapeutics
Last Price:
10.01
Seasonality Move:
12.09%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing slight selling pressure.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.52 | Sell |
| 20-day SMA: | 10.89 | Sell |
| 50-day SMA: | 13.07 | Sell |
| 200-day SMA: | 13.45 | Sell |
| 8-day EMA: | 10.47 | Sell |
| 20-day EMA: | 11.22 | Sell |
| 50-day EMA: | 12.31 | Sell |
| 200-day EMA: | 12.4 | Sell |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 32.47 | Sell |
| Chaikin Money Flow: | -71841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Y-mAbs Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 10.01 while YMAB 8-day simple moving average is 10.52, which is a Sell signal.
- The stock price of YMAB is 10.01 while Y-mAbs Therapeutics 20-day SMA is 10.89, which makes it a Sell.
- Y-mAbs Therapeutics 50-day simple moving average is 13.07 while YMAB share price is 10.01, making it a Sell technically.
- YMAB stock price is 10.01 and Y-mAbs Therapeutics 200-day simple moving average is 13.45, creating a Sell signal.
YMAB Technical Analysis vs Fundamental Analysis
Sell
29
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a Sell
The current Y-mAbs Therapeutics [YMAB] share price is $10.01. The Score for YMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
448.34M
Price in USD:
10.01
Share Volume:
167.63K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
20.90
52-Week Low:
6.09
Sell
29
Y-mAbs Therapeutics (YMAB)
is a Sell
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?
The Y-mAbs Therapeutics stock price is 10.01 USD today. -
Will YMAB stock go up or go down?
Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Y-mAbs Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 10.01 while YMAB 8-day exponential moving average is 10.47, which is a Sell signal.
- The stock price of YMAB is 10.01 while Y-mAbs Therapeutics 20-day EMA is 11.22, which makes it a Sell.
- Y-mAbs Therapeutics 50-day exponential moving average is 12.31 while YMAB share price is 10.01, making it a Sell technically.
- YMAB stock price is 10.01 and Y-mAbs Therapeutics 200-day simple moving average is 12.40, creating a Sell signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
- YMAB Moving Average Covergence Divergence (MACD) indicator is -0.84, suggesting Y-mAbs Therapeutics is a Sell
- Y-mAbs Therapeutics Relative Strength Index (RSI) is 32.47, which suggest Y-mAbs Therapeutics is oversold
- The Bollinger Bands (25) for Y-mAbs Therapeutics is ( - ), which suggest Y-mAbs Therapeutics is a Buy
- The Bollinger Bands (100) for Y-mAbs Therapeutics is ( - ), which suggest Y-mAbs Therapeutics is a Buy
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.